Effect of Liraglutide on Cardiometabolic Risk Profile in People with Coronary Artery Disease with or without Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Effect of Liraglutide on Cardiometabolic Risk Profile in People with Coronary Artery Disease with or without Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Whether liraglutide use improves cardiometabolic risk factors in different subsets of subjects with coronary artery disease (CAD) remains unclear. In a systematic review and meta-analysis, we quantified the effects of liraglutide on cardiometabolic risk profile in subjects with CAD with...

Full description

Bibliographic Details
Main Authors: Peyman Nowrouzi-Sohrabi, Negin Soroush, Reza Tabrizi, Mojtaba Shabani-Borujeni, Shahla Rezaei, Fatemeh Jafari, Mahnaz Hosseini-Bensenjan, Bruno H. Stricker, Mandy van Hoek, Fariba Ahmadizar
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Pharmacology
Subjects:
liraglutide
cardiometabolic profiles
coronary artery disease
systematic review
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.618208/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.618208/full

Similar Items